Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity : European Journal of Gastroenterology & Hepatology

Secondary Logo

Journal Logo

Original Articles: Diagnosis in Liver Disease

Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity

Lassailly, Guillaumea,b; Caiazzo, Robertc,d; Hollebecque, Antoinea,b; Buob, Davide; Leteurtre, Emmanuellee; Arnalsteen, Laurentc,d; Louvet, Alexandrea,b; Pigeyre, Marief; Raverdy, Violetad; Verkindt, Hélèned; Six, Marie Franced; Eberle, Caroled; Patrice, Alexandred; Dharancy, Sébastiena,b; Romon, Moniquef; Pattou, Françoisc,d; Mathurin, Philippea,b

Author Information
European Journal of Gastroenterology & Hepatology 23(6):p 499-506, June 2011. | DOI: 10.1097/MEG.0b013e3283464111

Abstract

© 2011 Lippincott Williams & Wilkins, Inc.

You can read the full text of this article if you:

Access through Ovid